If history is any guide, there may be trouble ahead for shares of Novartis (NYSE:NVS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Sandoz, a global leader in generic and biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a proposed first-of-a-kind biosimilar natalizumab, developed by Polpharma Biologics.
HC Wainwright initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $28, citing a potentially best-in-class…
U.S. stocks closed sharply higher, with the Dow Jones gaining more than 750 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.
U.S. stocks closed sharply higher, with the Dow Jones gaining more than 750 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.